The import of medicaments mixed together for therapeutic use to Brazil has been forecasted to increase steadily from 2024 to 2028. Starting from a value of 187.27 million USD in 2024, it is expected to reach 205.95 million USD by 2028. The year-on-year variation percentages are as follows: from 2024 to 2025 the increase is 2.57%, from 2025 to 2026 it is 2.46%, from 2026 to 2027 it is 2.35%, and from 2027 to 2028 it is 2.25%. The compound annual growth rate (CAGR) for the five-year period from 2024 to 2028 is approximately 2.41%.
In 2023, the actual value stood at 182.35 million USD. This indicates a consistent upward trend in the importation of these medicaments, emphasizing the growing demand for therapeutic solutions in Brazil.
Future trends to watch for include advancements in personalized medicine, potential regulatory changes impacting imports, and broader economic factors that could influence healthcare spending. Monitoring pharmaceutical innovation and public healthcare policies will be essential to understanding future market dynamics.
